South Africa Finalises a R1.5Billion Partnership with European Investment Bank, Biovac….details

South Africa has finalized a R1.5 billion agreement with the European Investment Bank and Biovac to establish Africa’s first fully integrated vaccine production facility. Scheduled for completion in 2028, the plant will begin with oral cholera vaccines before expanding to polio, pneumonia, and meningitis.

The initiative deepens economic ties with the European Union as South Africa broadens partnerships amid tensions with the United States. Additionally, the cabinet underscored the country’s rapid hantavirus response, highlighting its strong disease monitoring and medical expertise.

….stay tuned for more!